外体衍生的miRNAs在糖尿病伤口血管生成中的作用
Wen-Ting Chen1, Yi Luo1,2, Xue-Mei Chen1,3
1Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China.
Molecular and cellular biochemistry
|October 27, 2023
概括
来自干细胞的外体微RNA (miRNA) 显示出通过改善血管形成 (血管生成) 来治疗慢性糖尿病伤口的前景. 这篇评论探讨了它们在糖尿病伤口愈合中的治疗潜力.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 分子生物学分子生物学
背景情况:
- 慢性伤口是糖尿病的重要并发症,通常与血管生成受损有关.
- 传统疗法为糖尿病伤口愈合提供了有限的解决方案.
- 干细胞的副因子,特别是外体衍生微RNA (miRNA),正在成为强大的治疗剂.
研究的目的:
- 在糖尿病伤口愈合中审查外体衍生的miRNAs的病理生理学.
- 阐明底层机制,重点关注血管生成调节.
- 突出外体衍生的miRNAs对于糖尿病伤口修复的治疗潜力.
主要方法:
- 对外体衍生的miRNA和糖尿病伤口愈合研究的文献综述.
- 对由miRNA介导的血管生成调节的机制的分析.
- 综合关于治疗应用的当前知识.
主要成果:
- 外体衍生的miRNAs在调节血管功能和皮肤伤口修复方面发挥着至关重要的作用.
- 这些miRNAs可以通过恢复血管生成来减轻糖尿病伤口病原性.
- 证据支持它们在各种疾病模型中的治疗应用,包括糖尿病伤口.
结论:
- 外基因组衍生的miRNAs代表了慢性糖尿病伤口的有前途的治疗策略.
- 通过外体衍生的miRNA恢复血管生成是改善糖尿病伤口愈合的关键机制.
- 需要进一步的研究才能充分利用它们的再生潜力.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Mechanism of Angiogenesis
5.5K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.5K


